pentosidine has been researched along with hydralazine in 1 studies
| Studies (pentosidine) | Trials (pentosidine) | Recent Studies (post-2010) (pentosidine) | Studies (hydralazine) | Trials (hydralazine) | Recent Studies (post-2010) (hydralazine) |
|---|---|---|---|---|---|
| 577 | 34 | 205 | 4,580 | 364 | 393 |
| Protein | Taxonomy | pentosidine (IC50) | hydralazine (IC50) |
|---|---|---|---|
| Myeloperoxidase | Homo sapiens (human) | 1.265 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.649 | |
| Lactoperoxidase | Bos taurus (cattle) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H | 1 |
1 other study(ies) available for pentosidine and hydralazine
| Article | Year |
|---|---|
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles | 2003 |